Dry powder formulation comprising a pharmaceutical combination of tiotropium bromide, formoterol fumarate and mometasone furoate
Реферат: A pharmaceutical composition comprising tiotropium bromide, formoterol fumarate and mometasone furoate, and its use in the symptomatic and/or prophylactic treatment of respiratory diseases especially asthma, allergic rhinitis, chronic obstructive pulmonary disease
Dry powder formulations administered by the inhalation route comprising a combination of tiotropium bromide, salmeterol xynafoate and fluticasone propionate.
Номер патента: EP2528596A1. Автор: Mahmut Bilgic. Владелец: Individual. Дата публикации: 2012-12-05.